Diabetes Nutrition Market Revenue to Attain USD 23.53 Bn by 2033

18 Aug 2025

Share :

Table of Content

1. Diabetes Nutrition Market Revenue and Trends 2025 to 2033 2. What are the Key Factors Boosting the Growth of the Diabetes Nutrition Market? 3. Segment Insights 4. Regional Insights 5. Diabetes Nutrition Market Coverage 6. Diabetes Nutrition Market Key Players

Diabetes Nutrition Market Revenue and Trends 2025 to 2033

The global diabetes nutrition market revenue reached USD 13.54 billion in 2025 and is predicted to attain around USD 23.53 billion by 2033 with a CAGR of 7.15%. The market growth is attributed to increasing global diabetes prevalence, growing awareness of health, and rising demand for personalized, clinically proven dietary solutions.

What are the Key Factors Boosting the Growth of the Diabetes Nutrition Market?

The market for diabetes nutrition is experiencing robust growth, driven by the increasing number of cases of diabetes across the world, heightened health awareness, and a shift toward preventive healthcare approaches. The demand for specialized nutrition products, including dietary items, that are developed to manage blood sugar levels is escalating due to the rise in sedentary lifestyles and unhealthy dietary habits. Advances in medical nutrition science and the growing popularity of functional foods and supplements are supporting market growth. The demand for novel formulations, particularly low glycemic, high-fiber, and high-protein formulations, is rising.

Government and public health campaigns, alongside recommendations from healthcare professionals, are also contributing to the increased utilization of diabetes nutrition. Moreover, the accessibility of diabetes nutrition products is being increased through e-commerce platforms and digital tools, catering to both newly diagnosed and long-term diabetes patients seeking sustainable and clinically sound nutritional solutions. There is continuous need for innovative products that offer better taste and improved nutritional profile, opening up new growth opportunities.

Segment Insights

• By product type, the medical nutrition for diabetes segment held the largest share of the market in 2024. This is due to the proven effectiveness of medical nutrition in managing diabetes. Changing medical needs and trend toward personalized nutrition further bolstered segmental growth.
• By age group, the adults (18–64 years) segment dominated the market in 2024, driven by lifestyle factors contributing to diabetes, a desire for proactive health management, and personalized dietary interventions. High prevalence of diabetes in adults and their greater health awareness and purchasing power also contribute to market expansion.
• By form, the powder segment led the market in 2024. This is mainly due to its high adoption, driven by its convenient use, longer shelf life, versatility, cost-effectiveness, and ease of use.
• By end-user, the type 2 diabetes patients segment sustained dominance while holding the largest share in 2024. This is mainly due to its high prevalence, driven by changes in lifestyle habits, and the need for specialized nutritional support. This diabetes type often requires regular dietary management solutions, contributing to segmental growth.
• By sales channel, the supermarkets/hypermarkets segment contributed the largest market share in 2024 due to its broad accessibility, consumer trust, product variety, and convenience.

Regional Insights

North America dominated the diabetes nutrition market in 2024, driven by high diabetes prevalence, a robust healthcare system, and increased consumer knowledge of disease management. The region's strong research and development efforts foster rapid innovation in product formulations, particularly low-glycemic and nutrient-rich options. Government programs and funding, along with insurance coverage for medical nutrition services, provide additional support. The established retail network and growing online purchasing options ensure easy access to diabetes-focused foods and supplements for patients and health-conscious consumers.

Asia Pacific is expected to experience rapid growth in the coming years, driven by changing dietary habits and rising prevalence of diabetes. Rising disposable incomes and health consciousness among middle class population are fueling the demand for affordable, quality nutritional options for individuals with diabetes. Governments around the region are promoting public awareness through campaigns and screening programs, emphasizing early diagnosis and dietary intervention. Expanding distribution channels, including supermarkets and online retailers, are making diabetes nutrition products more accessible in both urban and semi-urban areas.

Diabetes Nutrition Market Coverage

Recent Development

• On August 13, 2025, Eli Lilly introduced the Mounjaro KwikPen, a once-weekly injectable for diabetes and weight loss, in India. This launch challenges Novo Nordisk’s Wegovy in the Indian market. (Source: https://www.reuters.com)

Diabetes Nutrition Market Key Players

• Abbott Laboratories
• Nestlé Health Science
• Danone S.A.
• Fresenius Kabi AG
• Glanbia PLC
• Mead Johnson Nutrition (Reckitt)
• Unilever PLC
• Kellogg Company
• PepsiCo Inc.
• The Hershey Company (Sugar-Free Line)
• The Kraft Heinz Company
• GlaxoSmithKline Consumer Healthcare
• Amway Corp.
• Herbalife Nutrition Ltd.
• Bayer AG (Consumer Health)
• BASF SE (Nutrition & Health)
• Ajinomoto Co., Inc.
• Sun Pharma Nutritionals
• Nutricia (A Danone Company)
• Medtrition Inc. 

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6583

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344